(CTPNV) CTP - Overview
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL00150006R6
Stock: Industrial Properties, Office Campuses, Solar Energy
Total Rating 48
Risk 76
Buy Signal -0.12
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.60% |
| Yield on Cost 5y | 5.06% |
| Yield CAGR 5y | 37.63% |
| Payout Consistency | 100.0% |
| Payout Ratio | 33.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.5% |
| Relative Tail Risk | -2.81% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.63 |
| Alpha | 13.19 |
| Character TTM | |
|---|---|
| Beta | -0.049 |
| Beta Downside | 0.072 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.34% |
| CAGR/Max DD | 1.07 |
Description: CTPNV CTP January 07, 2026
CTP N.V. (AS:CTPNV) is a Dutch-registered real-estate firm that develops, owns, operates, and leases a diversified portfolio of commercial assets across Western, Central, and Eastern Europe. Its core offerings include logistics-type industrial spaces (warehousing, manufacturing, R&D), city-center office campuses, mixed-use parks, and a growing solar-energy segment, complemented by retail, hotel, and ancillary property operations.
Key quantitative signals (as of FY 2023) show an average occupancy of ≈ 94 % across its industrial portfolio, an EBITDA margin of ~ 45 % on a €1.2 bn revenue base, and a net debt-to-EBITDA ratio of 1.3×, indicating moderate leverage. The company’s performance is closely tied to macro-drivers such as EU logistics demand growth (≈ 5 % CAGR), the European Green Deal’s incentives for solar and energy-efficient buildings, and the prevailing European Central Bank policy rate, which influences financing costs for real-estate development.
For a deeper, data-rich assessment of CTP N.V.’s valuation dynamics, you may find the analytics on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 1.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.29 > 1.0 |
| NWC/Revenue: -26.96% < 20% (prev 97.47%; Δ -124.4% < -1%) |
| CFO/TA 0.02 > 3% & CFO 403.6m > Net Income 1.21b |
| Net Debt (7.98b) to EBITDA (1.59b): 5.03 < 3 |
| Current Ratio: 0.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (479.3m) vs 12m ago 5.25% < -2% |
| Gross Margin: 79.01% > 18% (prev 0.81%; Δ 7820 % > 0.5%) |
| Asset Turnover: 5.25% > 50% (prev 4.65%; Δ 0.60% > 0%) |
| Interest Coverage Ratio: 7.28 > 6 (EBITDA TTM 1.59b / Interest Expense TTM 215.7m) |
Altman Z'' 1.80
| A: -0.01 (Total Current Assets 1.15b - Total Current Liabilities 1.41b) / Total Assets 19.42b |
| B: 0.26 (Retained Earnings 4.97b / Total Assets 19.42b) |
| C: 0.09 (EBIT TTM 1.57b / Avg Total Assets 18.25b) |
| D: 0.45 (Book Value of Equity 5.08b / Total Liabilities 11.18b) |
| Altman-Z'' Score: 1.80 = BBB |
Beneish M -2.64
| DSRI: 1.19 (Receivables 384.5m/268.7m, Revenue 958.4m/794.4m) |
| GMI: 1.02 (GM 79.01% / 80.82%) |
| AQI: 1.04 (AQ_t 0.93 / AQ_t-1 0.89) |
| SGI: 1.21 (Revenue 958.4m / 794.4m) |
| TATA: 0.04 (NI 1.21b - CFO 403.6m) / TA 19.42b) |
| Beneish M-Score: -2.64 (Cap -4..+1) = A |
What is the price of CTPNV shares?
As of February 07, 2026, the stock is trading at EUR 18.52 with a total of 132,335 shares traded.
Over the past week, the price has changed by +1.09%, over one month by +2.89%, over three months by +2.66% and over the past year by +18.02%.
Over the past week, the price has changed by +1.09%, over one month by +2.89%, over three months by +2.66% and over the past year by +18.02%.
Is CTPNV a buy, sell or hold?
CTP has no consensus analysts rating.
What are the forecasts/targets for the CTPNV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22.2 | 19.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 21.2 | 14.6% |
CTPNV Fundamental Data Overview February 03, 2026
Market Cap USD = 10.36b (8.78b EUR * 1.1801 EUR.USD)
P/E Trailing = 7.1843
P/E Forward = 18.9394
P/S = 9.172
P/B = 1.0674
P/EG = 2.7596
Revenue TTM = 958.4m EUR
EBIT TTM = 1.57b EUR
EBITDA TTM = 1.59b EUR
Long Term Debt = 7.48b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.00b EUR (from shortTermDebt, last quarter)
Debt = 9.04b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.98b EUR (from netDebt column, last quarter)
Enterprise Value = 16.77b EUR (8.78b + Debt 9.04b - CCE 1.05b)
Interest Coverage Ratio = 7.28 (Ebit TTM 1.57b / Interest Expense TTM 215.7m)
EV/FCF = 45.03x (Enterprise Value 16.77b / FCF TTM 372.3m)
FCF Yield = 2.22% (FCF TTM 372.3m / Enterprise Value 16.77b)
FCF Margin = 38.85% (FCF TTM 372.3m / Revenue TTM 958.4m)
Net Margin = 126.0% (Net Income TTM 1.21b / Revenue TTM 958.4m)
Gross Margin = 79.01% ((Revenue TTM 958.4m - Cost of Revenue TTM 201.2m) / Revenue TTM)
Gross Margin QoQ = 80.19% (prev 83.82%)
Tobins Q-Ratio = 0.86 (Enterprise Value 16.77b / Total Assets 19.42b)
Interest Expense / Debt = 0.81% (Interest Expense 73.2m / Debt 9.04b)
Taxrate = 18.70% (54.5m / 291.5m)
NOPAT = 1.28b (EBIT 1.57b * (1 - 18.70%))
Current Ratio = 0.82 (Total Current Assets 1.15b / Total Current Liabilities 1.41b)
Debt / Equity = 1.10 (Debt 9.04b / totalStockholderEquity, last quarter 8.24b)
Debt / EBITDA = 5.03 (Net Debt 7.98b / EBITDA 1.59b)
Debt / FCF = 21.45 (Net Debt 7.98b / FCF TTM 372.3m)
Total Stockholder Equity = 7.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.62% (Net Income 1.21b / Total Assets 19.42b)
RoE = 15.49% (Net Income TTM 1.21b / Total Stockholder Equity 7.80b)
RoCE = 10.28% (EBIT 1.57b / Capital Employed (Equity 7.80b + L.T.Debt 7.48b))
RoIC = 7.85% (NOPAT 1.28b / Invested Capital 16.27b)
WACC = 3.16% (E(8.78b)/V(17.82b) * Re(5.74%) + D(9.04b)/V(17.82b) * Rd(0.81%) * (1-Tc(0.19)))
Discount Rate = 5.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 3.41%
[DCF Debug] Terminal Value 87.45% ; FCFF base≈334.2m ; Y1≈377.0m ; Y5≈508.0m
Fair Price DCF = 14.55 (EV 14.96b - Net Debt 7.98b = Equity 6.98b / Shares 479.3m; r=5.90% [WACC]; 5y FCF grow 14.90% → 2.90% )
EPS Correlation: 39.56 | EPS CAGR: 49.30% | SUE: -1.27 | # QB: 0
Revenue Correlation: 95.28 | Revenue CAGR: 23.94% | SUE: 0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=0.97 | Chg30d=-0.011 | Revisions Net=-2 | Growth EPS=+13.6% | Growth Revenue=+15.6%
P/E Trailing = 7.1843
P/E Forward = 18.9394
P/S = 9.172
P/B = 1.0674
P/EG = 2.7596
Revenue TTM = 958.4m EUR
EBIT TTM = 1.57b EUR
EBITDA TTM = 1.59b EUR
Long Term Debt = 7.48b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.00b EUR (from shortTermDebt, last quarter)
Debt = 9.04b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.98b EUR (from netDebt column, last quarter)
Enterprise Value = 16.77b EUR (8.78b + Debt 9.04b - CCE 1.05b)
Interest Coverage Ratio = 7.28 (Ebit TTM 1.57b / Interest Expense TTM 215.7m)
EV/FCF = 45.03x (Enterprise Value 16.77b / FCF TTM 372.3m)
FCF Yield = 2.22% (FCF TTM 372.3m / Enterprise Value 16.77b)
FCF Margin = 38.85% (FCF TTM 372.3m / Revenue TTM 958.4m)
Net Margin = 126.0% (Net Income TTM 1.21b / Revenue TTM 958.4m)
Gross Margin = 79.01% ((Revenue TTM 958.4m - Cost of Revenue TTM 201.2m) / Revenue TTM)
Gross Margin QoQ = 80.19% (prev 83.82%)
Tobins Q-Ratio = 0.86 (Enterprise Value 16.77b / Total Assets 19.42b)
Interest Expense / Debt = 0.81% (Interest Expense 73.2m / Debt 9.04b)
Taxrate = 18.70% (54.5m / 291.5m)
NOPAT = 1.28b (EBIT 1.57b * (1 - 18.70%))
Current Ratio = 0.82 (Total Current Assets 1.15b / Total Current Liabilities 1.41b)
Debt / Equity = 1.10 (Debt 9.04b / totalStockholderEquity, last quarter 8.24b)
Debt / EBITDA = 5.03 (Net Debt 7.98b / EBITDA 1.59b)
Debt / FCF = 21.45 (Net Debt 7.98b / FCF TTM 372.3m)
Total Stockholder Equity = 7.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.62% (Net Income 1.21b / Total Assets 19.42b)
RoE = 15.49% (Net Income TTM 1.21b / Total Stockholder Equity 7.80b)
RoCE = 10.28% (EBIT 1.57b / Capital Employed (Equity 7.80b + L.T.Debt 7.48b))
RoIC = 7.85% (NOPAT 1.28b / Invested Capital 16.27b)
WACC = 3.16% (E(8.78b)/V(17.82b) * Re(5.74%) + D(9.04b)/V(17.82b) * Rd(0.81%) * (1-Tc(0.19)))
Discount Rate = 5.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 3.41%
[DCF Debug] Terminal Value 87.45% ; FCFF base≈334.2m ; Y1≈377.0m ; Y5≈508.0m
Fair Price DCF = 14.55 (EV 14.96b - Net Debt 7.98b = Equity 6.98b / Shares 479.3m; r=5.90% [WACC]; 5y FCF grow 14.90% → 2.90% )
EPS Correlation: 39.56 | EPS CAGR: 49.30% | SUE: -1.27 | # QB: 0
Revenue Correlation: 95.28 | Revenue CAGR: 23.94% | SUE: 0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=0.97 | Chg30d=-0.011 | Revisions Net=-2 | Growth EPS=+13.6% | Growth Revenue=+15.6%